| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.12.25 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 01.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 31.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.09.25 | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 143 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen | |
| 10.09.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08.25 | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,256 | +10,65 % | Plus Therapeutics Inc.: Plus Therapeutics Provides Business Update on REYOBIQ Clinical Program and U.S. CNSide Commercialization | HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 0,570 | +5,01 % | Oramed Pharmaceuticals Inc.: Oramed and Lifeward Announce Strategic Transaction | Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD Technology) to Lifeward and Positions Oramed as a Significant Shareholder
Oramed will transfer... ► Artikel lesen | |
| EKSO BIONICS | 10,550 | +12,71 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| IMUNON | 2,560 | -9,86 % | Imunon stock price target raised to $25 from $14 at H.C. Wainwright | ||
| BIOCEPT | - | - | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,834 | -7,44 % | Why Is Rockwell Medical Gaining Tuesday? | ||
| VIRIDIAN THERAPEUTICS | 26,980 | +9,10 % | Evercore ISI raises Viridian Therapeutics stock price target on subQ TED potential | ||
| SINTX TECHNOLOGIES | 2,940 | +3,16 % | SiNtx Technologies, Inc.: SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate | Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglichtSALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX"... ► Artikel lesen | |
| AETHLON MEDICAL | 2,290 | +7,01 % | Morning Market Movers: Powell Max, Kaixin Holdings, Acadia Healthcare, Aethlon Medical See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| NEURONETICS | 1,282 | -2,58 % | Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan | Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,062 | +3,36 % | hVIVO PLC - Trading Update | ||
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Der Aktienkurs der Münchner spiegle die mittelfristigen... ► Artikel lesen |